FacebookTwitterRedditEmail

Death By Tweetstorm: a Win-Win for Trump

Photograph by Nathaniel St. Clair

For lack of respirators, patients with severe respiratory distress from COVID-19 will die as the epidemic unfolds. A drug to treat the disease is urgently needed. But the US press subjected news about hydroxychloroquine, a potential treatment, to an excess of caution in response to a Trump tweetstorm. Journalists and health care professionals alike were whipsawed by the president’s irresponsible ballyhooing of the drug amid deprecatory assertions of “anecdotal” evidence by Anthony Fauci at the CDC.

This fast-moving story started picking up steam with results from a small trial of hydroxychloroquine to treat COVID-19 out of Marseilles, France, by a well-known infectious disease specialist, Didier Raoult. It follows upon another small study from China, also promising. The drug has been used to treat immune-related disease for more than 60 years. It deserves the serious consideration it’s getting from the Europeans and Chinese.

The French trial included 36 patients, 16 of whom were controls who did not receive the drug. The 20 remaining patients, all with confirmed COVID-19 infection, were treated with hydroxychloroquine for 14 days. Some were asymptomatic, others had symptoms. Six of the patients also received an antibiotic, azithromycin.

The striking result was diminished viral load in the treated patients. As Raoult and colleagues put it in their as-yet unpublished paper, “70% of hydroxychloroquine-treated patients were virologicaly cured comparing with 12.5% in the control group.” Although the mechanism of action with this virus is not known, it’s been biochemically well-characterized; it’s not snake oil.

In that context, Trump’s endorsement, laced with ignorance, made things worse. In response came Anthony Fauci’s March 20 mischaracterization of the data as “anecdotal.” He was soon more concessional in his comments but Trump’s words met their mark. The next day the New York Times reported that the drug was “being prescribed right and left.”

Trump’s tweets sewed confusion and nixed hopes for a rational scenario. Concern about insufficient supply, unruly demand, and hysteria are well-placed. A rational approach would have been for the government to ensure provision for hydroxychloroquine to coincide as much as possible with the certain-to-come spike in severe cases. On global stage, this is already happening.  Drug makers are ramping up production. Novartis says it’s donating up to 130 million doses of the drug to the global pandemic.

As with any potential treatment, results from a couple of small trials warrant caution. In the case of hydroxychloroquine, the drug has been around since 1955. It has well-known adverse effects in some patients — those with heart disease, for example. But its safety profile would not be a problem for most.

It should be added that calls for huge trials ahead of approving this drug are misplaced. Based on their results, Raoult and colleagues have calculated that just 48 patients would be required to further test hydroxychloroquine, 24 to receive the drug and 24 controls. That’s a small number, but large enough.  Eighty years ago, penicillin required just about 5 patients for the decision to scale up manufacture.

The news out of Raoult’s laboratory is possibly nothing, possibly game-changing; It could have given patients, doctors, and especially hospital administrators much-needed mental room for organization and thoughtful emergency planning. The drug could have been an antidote to fear that “the sky is falling,” as Cornelia Griggs wrote in The Times (Op-Ed, March 19). Now, as far as it concerns panic, it’s too late.

Trump’s tweetstorm about hydroxychloroquine during a medical emergency of historic proportion will cost lives. But for Trump himself, there’s no downside. If the drug works, he will cover himself in glory. If it doesn’t — well, his friend Fauci told you so.

More articles by:

John Galbraith Simmons is author, in collaboration with Justin A. Zivin MD, PhD, of tPA for Stroke: The Story of a Controversial Drug (Oxford Univ Press, 2010).

Weekend Edition
August 14, 2020
Friday - Sunday
Matthew Hoh
Lights! Camera! Kill! Hollywood, the Pentagon and Imperial Ambitions.
Joseph Grosso
Bloody Chicken: Inside the American Poultry Industry During the Time of COVID
Jeffrey St. Clair
Roaming Charges: It Had to be You
H. Bruce Franklin
August 12-22, 1945: Washington Starts the Korean and Vietnam Wars
Pete Dolack
Business as Usual Equals Many Extra Deaths from Global Warming
Paul Street
Whispers in the Asylum (Seven Days in August)
Richard Falk – Daniel Falcone
Predatory Capitalism and the Nuclear Threat in the Age of Trump
Paul Fitzgerald - Elizabeth Gould
‘Magical Thinking’ has Always Guided the US Role in Afghanistan
Ramzy Baroud
The Politics of War: What is Israel’s Endgame in Lebanon and Syria?
Ron Jacobs
It’s a Sick Country
Eve Ottenberg
Trump’s Plan: Gut Social Security, Bankrupt the States
Richard C. Gross
Trump’s Fake News
Jonathan Cook
How the Guardian Betrayed Not Only Corbyn But the Last Vestiges of British Democracy
Joseph Natoli
What Trump and the Republican Party Teach Us
Robert Fisk
Can Lebanon be Saved?
Brian Cloughley
Will Biden be Less Belligerent Than Trump?
Kenn Orphan
We Do Not Live in the World of Before
Kollibri terre Sonnenblume
Compromise & the Status Quo
Andrew Bacevich
Biden Wins, Then What?
Thomas Klikauer – Nadine Campbell
The Criminology of Global Warming
Michael Welton
Toppled Monuments and the Struggle For Symbolic Space
Prabir Purkayastha
Why 5G is the First Stage of a Tech War Between the U.S. and China
Daniel Beaumont
The Reign of Error
Adrian Treves – John Laundré
Science Does Not Support the Claims About Grizzly Hunting, Lethal Removal
David Rosen
A Moment of Social Crisis: Recalling the 1970s
Maximilian Werner
Who’s Afraid of the Big Bad Wolf: Textual Manipulations in Anti-wolf Rhetoric
Pritha Chandra
Online Education and the Struggle over Disposable Time
Robert Koehler
Learning from the Hibakushas
Seth Sandronsky
Teaching in a Pandemic: an Interview With Mercedes K. Schneider
Dean Baker
Financing Drug Development: What the Pandemic Has Taught Us
Greta Anderson
Blaming Mexican Wolves for Livestock Kills
Evaggelos Vallianatos
The Meaning of the Battle of Salamis
Mel Gurtov
The World Bank’s Poverty Illusion
Paul Gilk
The Great Question
Rev. Susan K. Williams Smith
Trump Doesn’t Want Law and Order
Martin Cherniack
Neo-conservatism: The Seductive Lure of Lying About History
Nicky Reid
Pick a Cold War, Any Cold War!
George Wuerthner
Zombie Legislation: the Latest Misguided Wildfire Bill
Lee Camp
The Execution of Elephants and Americans
Christopher Brauchli
I Read the News Today, Oh Boy…
Tony McKenna
The Truth About Prince Philip
Louis Proyect
MarxMail 2.0
Sidney Miralao
Get Military Recruiters Out of Our High Schools
Jon Hochschartner
Okra of Time
David Yearsley
Bringing Landscapes to Life: the Music of Johann Christian Bach
FacebookTwitterRedditEmail